Approvals/TGA/DROSPIRENONE/ ETHINYLOESTRADIOL-GH TABLETS 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack

Approved

STANDARD

DROSPIRENONE/ ETHINYLOESTRADIOL-GH TABLETS 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack

Lupin Australia Pty Limited🇦🇺 Therapeutic Goods Administration

Approval Id: ad18dcd80e43f4ed
Product Name: DROSPIRENONE/ ETHINYLOESTRADIOL-GH TABLETS 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack
Artg Id: 180562
Artg Name: DROSPIRENONE/ ETHINYLOESTRADIOL-GH TABLETS 3 mg/30 micrograms drospirenone/ethinylestradiol 3 mg/30 micrograms tablet blister pack
Sponsor: Lupin Australia Pty Limited
Company Detail Path: /organization/lupin-australia-pty-limited
Artg Date: 2012-01-20
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ad18dcd80e43f4ed

Type

Standard